Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Targeting flavonoids on modulation of metabolic syndrome

Texto completo
Autor(es):
Neri-Numa, Iramaia Angelica [1] ; Betim Cazarin, Cinthia Bau [2] ; Tasca Gois Ruiz, Ana Lucia [3] ; Paulino, Bruno Nicolau [4] ; Molina, Gustavo [5] ; Pastore, Glaucia Maria [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Lab Bioflavours & Bioact Cpds, UNICAMP, BR-13083862 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Dept Food & Nutr, Nutr & Metab Lab, UNICAMP, BR-13083862 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Fac Pharmaceut Sci, UNICAMP, BR-13083871 Campinas, SP - Brazil
[4] Fed Univ Amazonas UFAM, Fac Pharmaceut Sci, BR-69080900 Manaus, Amazonas - Brazil
[5] Fed Univ Jequitinhonha & Mucuri Valleys UFVJM, Inst Sci & Technol, Diamantina, MG - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo de Revisão
Fonte: Journal of Functional Foods; v. 73, OCT 2020.
Citações Web of Science: 0
Resumo

Metabolic Syndrome (MetS) is a complex condition associated with cardiovascular risk factors and diabetes. The weight gain, especially the accumulation of central adipose tissue, may be the first leading cause of the MetS. It is important to highlight that the lifestyle choices considered as modifiable risk factors contribute to the increase in the incidence of the MetS in the population, such as sedentarism and food intake. There is evidence in the literature concerning the benefits associated with the Mediterranean diet, which is rich in polyphenols. Therefore, the flavonoids are a class of non-nutrient that can be extensively studied mainly to elucidate the mechanisms related to the action of these compounds in the modulation of the microbiota, DNA methylation and health improvement. Thus, this review summarized evidence linking flavonoid intake to obesity, insulin resistance, T2DM and cardiovascular diseases. (AU)

Processo FAPESP: 15/50333-1 - Cobra: nova plataforma de descoberta de compostos para identificação rápida e de baixo custo de bioativo com efeitos benéficos originários de plantas brasileiras
Beneficiário:Glaucia Maria Pastore
Modalidade de apoio: Auxílio à Pesquisa - Temático